Skip to main content
. Author manuscript; available in PMC: 2015 Jan 13.
Published in final edited form as: Invest New Drugs. 2014 Mar 27;32(4):739–745. doi: 10.1007/s10637-014-0083-8

Table 2.

RO4929097-Related Adverse Events

Grade
Adverse Event
 1
 2
 3
 4
 Total
Confusion 1 1
Hyperglycemia 2 2
Fatigue 2 2
Dysgeusia 1 1
Lymphocyte Count Decreased 2 2
Hypophosphatemia 1 1
Total
3
5
0
1
9